Get the Stockscreener App
0.155
4.38%
-0.0071
Glucotrack Inc stock is traded at $0.155, with a volume of 1.48M.
It is down -4.38% in the last 24 hours and down -11.83% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$0.1621
Open:
$0.16
24h Volume:
1.48M
Relative Volume:
0.30
Market Cap:
$4.32M
Revenue:
-
Net Income/Loss:
$-8.74M
P/E Ratio:
-0.0756
EPS:
-2.05
Net Cash Flow:
$-8.25M
1W Performance:
-8.12%
1M Performance:
-11.83%
6M Performance:
-99.44%
1Y Performance:
-99.72%
1-Day Range:
$0.153
$0.1627
1-Week Range:
$0.1466
$0.1977
52-Week Range:
$0.1313
$62.60
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.155 | 4.32M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Glucotrack Inc Stock (GCTK) Latest News
Geode Capital Management LLC Increases Stock Holdings in GlucoTrack, Inc. (NASDAQ:GCTK) - Defense World
GlucoTrack Inc (GCTK) can make a big difference with a little luck - Sete News
Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial - Clinical Leader
GlucoTrack Releases Investor Presentation on April 29 - TipRanks
GlucoTrack Inc (NASDAQ:GCTK) stock crossing the finish line today - uspostnews.com
Can GlucoTrack Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Now Is The Time To Build A Position In GlucoTrack Inc (NASDAQ:GCTK) - Marketing Sentinel
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - ADVFN
It makes sense and dollars to buy GlucoTrack Inc (GCTK) stock - Sete News
Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews
GlucoTrack Joins EU Bionic Pancreas Initiative - TipRanks
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - The Manila Times
Major Breakthrough: Glucotrack Selected for EU's Revolutionary Bionic Pancreas Project - Stock Titan
Investing in GlucoTrack Inc (GCTK) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
GCTK stock plunges to 52-week low of $0.15 amid market turmoil By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low of $0.15 amid market turmoil - Investing.com India
Glucotrack faces Nasdaq delisting over share price rule - Investing.com Australia
Glucotrack faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis By Investing.com - Investing.com South Africa
6 Alternatives to Apple’s Non-Invasive Glucose Monitoring You Can Try Now - The Mac Observer
GlucoTrack Partners with OneTwo Analytics for AI-Driven Insights - TipRanks
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis - Investing.com Australia
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewswire
Game-Changing Implantable Glucose Monitor Partners With AI Firm for 3-Year Clinical Study - Stock Titan
Glucotrack Reports Transformative Year with Clinical Advances - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
GlucoTrack Advances with Clinical Trials and Funding Boost - TipRanks
Glucotrack, Inc. SEC 10-K Report - TradingView
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week - MSN
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence - Investing.com India
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
GlucoTrack Inc (NASDAQ: GCTK) Analysts Prediction On How Much It Could Rise - Stocks Register
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last - Asianet Newsable
Why Did GlucoTrack Plunge 15.72%? - AInvest
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack to Present at TechBio Showcase™ 2025 - The Globe and Mail
GCTK stock plunges to 52-week low, touches $0.31 By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
GCTK stock plunges to 52-week low, touches $0.31 - Investing.com
Pre-market Movers: IBO, ALUR, GCTK, TELA... - RTTNews
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):